Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Wederson M. Claudino"'
Autor:
Shesh N. Rai, Alfred B. Jenson, Wederson M. Claudino, Sujita Khanal, Mark J. Amsbaugh, Dharamvir Jain, Paul Tennant, Jeffrey M. Bumpous, Cesar A. Perez, C. Silverman, Rebecca Redman, Rahul Gosain, Teresa L. Roberts, Xiaoyong Wu, Mehran Yusuf, Neal Dunlap
Publikováno v:
Oral Oncology. 67:24-28
Objectives To compare the outcomes and toxicity of high-dose cisplatin (HDC) versus weekly cisplatin (WC) definitive chemoradiotherapy (CRT) for patients with human papillomavirus (HPV) related oropharyngeal squamous cell carcinoma (SCCOPx). Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f27239ba05ff139ff66503133f72ac31
https://doi.org/10.1016/j.oraloncology.2017.01.010
https://doi.org/10.1016/j.oraloncology.2017.01.010
Autor:
Priscila H. Goncalves, Fazlul H. Sarkar, Philip A. Philip, Angelo Di Leo, Wederson M. Claudino
Publikováno v:
Critical Reviews in Oncology/Hematology. 84:1-7
The field of oncology is a rapidly evolving science mostly due to extensive basic, translational and clinical research which have provided more insights into the tumor biology and set grounds for the development of new therapies. Metabolomics is the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da7a77930ba3950394e2815b792a974c
https://doi.org/10.1016/j.critrevonc.2012.02.009
https://doi.org/10.1016/j.critrevonc.2012.02.009
Autor:
Ivano Bertini, Patrick G. Morris, Leonardo Tenori, Edoardo Saccenti, Patrizia Bernini, A. Di Leo, Stefano Nepi, Claudio Luchinat, Elena Zafarana, Silvia Cappadona, Catherine Oakman, Laura Biganzoli, Monica Fornier, Wederson M. Claudino, A. Battaglia
Publikováno v:
Annals of Oncology; Vol 22
Background Prognostic tools in early breast cancer are inadequate. The evolving field of metabolomics may allow more accurate identification of patients with residual micrometastases. Patients and methods Forty-four early breast cancer patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8172f2ae4fd8e1ef668accadbe053355
Autor:
Denis Larsimont, Marta Pestrin, Sara Licitra, Wederson M. Claudino, Angelo Di Leo, Laura Biganzoli
Publikováno v:
European Journal of Cancer. 44:2791-2798
Purpose This manuscript reviews and discusses results from randomised clinical studies evaluating topoisomerase II alpha (topo II) as a marker predicting anthracyclines’ activity in early breast cancer patients. Methods A Medline search has led to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::975daccbb437aa68e1a358e8d1fd0a45
https://doi.org/10.1016/j.ejca.2008.09.014
https://doi.org/10.1016/j.ejca.2008.09.014
Autor:
Silvia Bessi, Laura Biganzoli, Wederson M. Claudino, Donato Colangiuli, Marta Pestrin, A. Di Leo
Publikováno v:
Annals of Oncology. 18:xii8-xii14
Despite significant improvements in the treatment and outcomes of early-stage breast cancer, the quest continues to find biological and molecular markers that would enable earlier diagnosis or better prediction of treatment efficacy and toxicity. Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5edea628e5ef56e9cbfa8d51d767449
https://doi.org/10.1093/annonc/mdm533
https://doi.org/10.1093/annonc/mdm533
Autor:
Teresa L. Roberts, C. Silverman, Alfred B. Jenson, Cesar A. Perez, Mehran Yusuf, Xiaoyong Wu, Jorge Arturo Rios-Perez, Sujita Khanal, Wederson M. Claudino, Dharamvir Jain, Rebecca Redman, Mark J. Amsbaugh, Neal Dunlap, Shesh N. Rai, Paul Tennant
Publikováno v:
Journal of Clinical Oncology. 34:6074-6074
6074Background: Definitive concurrent chemoradiation (CRT) is a standard treatment for patients (pts) with squamous cell carcinoma of the oropharynx (SCCOPx). We compared the outcomes and toxicity ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b7f015bd184f3da593a3e962f75c9b5
https://doi.org/10.1200/jco.2016.34.15_suppl.6074
https://doi.org/10.1200/jco.2016.34.15_suppl.6074
Autor:
Liz Wilson, Xiaoyong Wu, Teresa L. Roberts, Cesar A. Perez, Craig L. Silverman, Neal Dunlap, Rebecca Redman, Mehran Yusuf, Shesh N. Rai, Wederson M. Claudino, Elizabeth Cash, Mark J. Amsbaugh, L. Hall Volz, Alfred B. Jenson, Paul Tennant, Jeffrey M. Bumpous, Sujita Khanal
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 94:895
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91690d71a2cdb72c05e86c209ccea391
https://doi.org/10.1016/j.ijrobp.2015.12.097
https://doi.org/10.1016/j.ijrobp.2015.12.097
Autor:
Ivano Bertini, Stefano Nepi, Catherine Oakman, Laura Biganzoli, Leonardo Tenori, Wederson M. Claudino, Angelo Di Leo, Patrizia Bernini, M. Arbushites, Silvia Cappadona, Claudio Luchinat
Metabolomics, a global study of metabolites and small molecules, is a novel expanding field. In this pilot study, metabolomics has been applied to serum samples from women with metastatic breast cancer to explore outcomes and response to treatment.Pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d906620851ba2c71f37ac20664b88e9
https://europepmc.org/articles/PMC5528357/
https://europepmc.org/articles/PMC5528357/
Autor:
Jatin Shah, Luiz F. L. Reis, Ricardo Pietrobon, Elias Carvalho, Adelia Portero Batilana, Wederson M. Claudino, Rafael A. Schmerling
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 6, p e39671 (2012)
PLoS ONE, Vol 7, Iss 6, p e39671 (2012)
BACKGROUND: With the exponential expansion of clinical trials conducted in (Brazil, Russia, India, and China) and VISTA (Vietnam, Indonesia, South Africa, Turkey, and Argentina) countries, corresponding gains in cost and enrolment efficiency quickly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ef71925ede7822b784f95543ad2b042
https://pubmed.ncbi.nlm.nih.gov/22768105
https://pubmed.ncbi.nlm.nih.gov/22768105
Publikováno v:
Breast (Edinburgh, Scotland). 16
It is largely known that clinical activity of a given cytotoxic agent may vary between different patients. This suggests that breast cancer sub-types can be identified within the endocrine-resistant cohort, each of them with a specific degree of sens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b40c155c5b132273e66c60023da2c43
https://pubmed.ncbi.nlm.nih.gov/17720501
https://pubmed.ncbi.nlm.nih.gov/17720501